Literature DB >> 27500914

Optimal prevention of transfusion-transmitted cytomegalovirus (TTCMV) infection by modern leukocyte reduction alone: CMV sero/antibody-negative donors needed only for leukocyte products.

Ronald G Strauss1.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27500914     DOI: 10.1111/trf.13683

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  2 in total

Review 1.  Risk of cytomegalovirus transmission by blood products after solid organ transplantation.

Authors:  Deborah Jebakumar; Patti Bryant; Walter Linz
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-04-23

2.  Transfusion practice in neonates.

Authors:  Do-Hyun Kim
Journal:  Korean J Pediatr       Date:  2018-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.